Selected article for: "ARB therapy and non acei ARB therapy"
Author: Zhichao Feng; Jennifer Li; Shanhu Yao; Qizhi Yu; Wenming Zhou; Xiaowen Mao; Huiling Li; Wendi Kang; Xin Ouyang; Ji Mei; Qiuhua Zeng; Jincai Liu; Xiaoqian Ma; Pengfei Rong; Wei Wang
Title: The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis
  • Document date: 2020_4_10
    • ID: k65501xp_35
    Snippet: In this study, we described the use of several adjuvant treatments in preventing severe pneumonia development in COVID-19 patients. Hypertensive patients who received ACEI/ARB therapy had a lower risk of developing severe pneumonia compared with those on non-ACEI/ARB antihypertensive therapy, which suggested that ACEI/ARB therapy may be protective from severe pulmonary injury for hypertensive patients. However, these results should be interpreted.....
    Document: In this study, we described the use of several adjuvant treatments in preventing severe pneumonia development in COVID-19 patients. Hypertensive patients who received ACEI/ARB therapy had a lower risk of developing severe pneumonia compared with those on non-ACEI/ARB antihypertensive therapy, which suggested that ACEI/ARB therapy may be protective from severe pulmonary injury for hypertensive patients. However, these results should be interpreted with caution owing to potential bias and residual confounders in this observational study.

    Search related documents:
    Co phrase search for related documents
    • ACEI ARB therapy and antihypertensive therapy: 1, 2, 3, 4
    • ACEI ARB therapy and ARB antihypertensive therapy: 1, 2, 3
    • ACEI ARB therapy and ARB therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ACEI ARB therapy and low risk: 1
    • ACEI ARB therapy and observational study: 1, 2, 3, 4
    • ACEI ARB therapy and pneumonia development: 1
    • adjuvant treatment and ARB therapy: 1
    • adjuvant treatment and low risk: 1, 2
    • adjuvant treatment and observational study: 1, 2
    • antihypertensive therapy and ARB antihypertensive therapy: 1, 2, 3, 4
    • antihypertensive therapy and ARB therapy: 1, 2, 3, 4, 5, 6
    • antihypertensive therapy and low risk: 1
    • antihypertensive therapy and observational study: 1, 2, 3
    • antihypertensive therapy and pneumonia development: 1
    • ARB antihypertensive therapy and observational study: 1
    • ARB antihypertensive therapy and pneumonia development: 1
    • ARB therapy and low risk: 1
    • ARB therapy and observational study: 1, 2, 3, 4, 5
    • ARB therapy and pneumonia development: 1